<img alt="" src="https://secure.perk0mean.com/171547.png" style="display:none;">


[Free Whitepaper]

Statistical Challenges in Preserving Integrity of Ongoing Clinical Trials During the COVID-19 Pandemic

Challenges, potential solutions for maintaining scientific accuracy and regulatory compliance.

The COVID-19 pandemic is an unparalleled global event that has caught all sectors of business off-guard. The pharmaceutical industry is a patient-centric one and is being impacted in ways not seen before. The implications of this situation are far-reaching and wide.

This whitepaper will discuss:

  • Challenges posed to clinical trials
  • Modifying the sample size
  • Estimands and missing data
  • Improving data quality through Centralized Statistical Monitoring
  • Solutions to maintaining scientific accuracy and regulatory compliance
  • The need for flexibility, without affecting patients’ safety and study validity


Whitepaper Preview:

Download this paper